Robert "Chip" T. Schooley (born November 10, 1949) is an American infectious disease physician, who is the Vice Chair of Academic Affairs, Senior Director of International Initiatives, and Co-Director at the Center for Innovative Phage Applications and Therapeutics (IPATH), at the University of California San Diego School of Medicine. He is an expert in HIV and hepatitis C (HCV) infection and treatment, and in 2016, was the first physician to treat a patient in the United States with intravenous bacteriophage therapy for a systemic bacterial infection.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| |
rdfs:comment
| - Robert "Chip" T. Schooley (born November 10, 1949) is an American infectious disease physician, who is the Vice Chair of Academic Affairs, Senior Director of International Initiatives, and Co-Director at the Center for Innovative Phage Applications and Therapeutics (IPATH), at the University of California San Diego School of Medicine. He is an expert in HIV and hepatitis C (HCV) infection and treatment, and in 2016, was the first physician to treat a patient in the United States with intravenous bacteriophage therapy for a systemic bacterial infection. (en)
|
foaf:name
| - Robert "Chip" T. Schooley (en)
|
name
| - Robert "Chip" T. Schooley (en)
|
foaf:depiction
| |
birth date
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
Link from a Wikipage to an external page
| |
sameAs
| |
workplaces
| - UC San Diego School of Medicine
University of Colorado
Harvard Medical School (en)
|
dbp:wikiPageUsesTemplate
| |
thumbnail
| |
alma mater
| - Johns Hopkins University School of Medicine (en)
|
birth date
| |
nationality
| |
residence
| - San Diego, California (en)
|
has abstract
| - Robert "Chip" T. Schooley (born November 10, 1949) is an American infectious disease physician, who is the Vice Chair of Academic Affairs, Senior Director of International Initiatives, and Co-Director at the Center for Innovative Phage Applications and Therapeutics (IPATH), at the University of California San Diego School of Medicine. He is an expert in HIV and hepatitis C (HCV) infection and treatment, and in 2016, was the first physician to treat a patient in the United States with intravenous bacteriophage therapy for a systemic bacterial infection. (en)
|
institution
| |
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
alma mater
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |
is editor
of | |
is editor
of | |
is person
of | |
is foaf:primaryTopic
of | |